IPHA - Innate Pharma S.A.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.67
DETAILS
HIGH:
$9.00
LOW:
$4.00
MEDIAN:
$7.00
CONSENSUS:
$6.67
UPSIDE:
256.68%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: IPHA has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.